Venetoclax (Venetoklaks)
| Use attributes for filter ! | |
| Molar mass | 868. 44 g/mol |
|---|---|
| Formula | C45H50ClN7O7S |
| Other names | GDC-0199, ABT-199, RG7601 |
| Trade name | Venclexta, Venclyxto |
| Elimination half-life | ~26 hours |
| ATC code | L01XX52 (WHO) |
| Music groups | Ibrutinib |
| Azacitidine | |
| Obinutuzumab | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951302 |
About Venetoclax (Venetoklaks)
Venetoclax, sold under the trade name Venclexta and Venclyxto, is a medication used to treat chronic lymphocytic leukemia.